Rodgers Richard J 4
4 · Opus Genetics, Inc. · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics Director Richard J. Rodgers Receives RSU Award
What Happened
Richard J. Rodgers, a director of Opus Genetics, was awarded 24,367 restricted stock units (RSUs) on April 20, 2026. The award is reported as an acquisition (code A) with a reported price of $0.00 (typical for compensation grants), so there was no cash paid by the insider.
Key Details
- Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (timely filing).
- Grant size: 24,367 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: Not specified in the filing.
- Footnote: The RSUs vest on the earlier of (a) one year from the grant date or (b) the day before the issuer’s next annual meeting after the grant date, and only if the reporting person continues service through the vesting date. (Footnote F1)
- Transaction code: A = Award/Grant.
Context
RSU grants are a form of compensation and typically vest over time; they are not an immediate cash purchase or sale. Because these RSUs vest based on service or a timing condition, this transaction reflects routine director compensation rather than an immediate market bet. As always, grants alone don’t indicate the insider’s near-term sentiment about the stock.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-20+24,367→ 343,022 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.